Inflammatory responses to psychological stress in fatigued breast cancer survivors: relationship to glucocorticoids
- PMID: 17008048
- DOI: 10.1016/j.bbi.2006.08.001
Inflammatory responses to psychological stress in fatigued breast cancer survivors: relationship to glucocorticoids
Abstract
Fatigue is a common problem following cancer treatment and our previous studies suggest that a chronic inflammatory process might contribute to cancer-related fatigue. However, immune responses to challenge have not yet been evaluated among individuals with cancer-related fatigue, and it is not known what mechanisms drive increased levels of inflammatory markers in fatigued cancer survivors. We have previously reported that fatigued breast cancer survivors show a blunted cortisol response to an experimental psychological stressor. In this report, we focus on inflammatory responses to this stressor and their relationship to circulating glucocorticoids and cellular sensitivity to glucocorticoid inhibition. Relative to non-fatigued control survivors, participants experiencing persistent fatigue showed significantly greater increases in LPS-stimulated production of IL-1beta and IL-6 following the stressor (Group x Time interaction: p<.05). Fatigued participants did not show any difference in cellular sensitivity to cortisol inhibition of cytokine production, but they did show significantly less salivary cortisol increase in the aftermath of the stressor. Moreover, blunted cortisol responses were associated with significantly increased production of IL-6 in response to LPS stimulation (p<.05). These data provide further evidence of enhanced inflammatory processes in fatigued breast cancer survivors and suggest that these processes may stem in part from decreased glucocorticoid response to stress.
Similar articles
-
Altered cortisol response to psychologic stress in breast cancer survivors with persistent fatigue.Psychosom Med. 2005 Mar-Apr;67(2):277-80. doi: 10.1097/01.psy.0000155666.55034.c6. Psychosom Med. 2005. PMID: 15784794
-
Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome.Psychoneuroendocrinology. 2005 Feb;30(2):188-98. doi: 10.1016/j.psyneuen.2004.06.008. Psychoneuroendocrinology. 2005. PMID: 15471616 Clinical Trial.
-
Diurnal cortisol rhythm and fatigue in breast cancer survivors.Psychoneuroendocrinology. 2005 Jan;30(1):92-100. doi: 10.1016/j.psyneuen.2004.06.003. Psychoneuroendocrinology. 2005. PMID: 15358446 Clinical Trial.
-
Cancer related fatigue: a focus on breast cancer and Hodgkin's disease survivors.Acta Oncol. 2007;46(4):474-9. doi: 10.1080/02841860701367845. Acta Oncol. 2007. PMID: 17497314 Review.
-
Why do we respond so differently? Reviewing determinants of human salivary cortisol responses to challenge.Psychoneuroendocrinology. 2009 Jan;34(1):2-18. doi: 10.1016/j.psyneuen.2008.10.004. Epub 2008 Nov 28. Psychoneuroendocrinology. 2009. PMID: 19041187 Review.
Cited by
-
The Role of Physical Activity in Managing Fatigue in Cancer Survivors.Curr Nutr Rep. 2018 Sep;7(3):59-69. doi: 10.1007/s13668-018-0234-1. Curr Nutr Rep. 2018. PMID: 30094747 Review.
-
Long-Term Fatigue and Cognitive Disorders in Breast Cancer Survivors.Cancers (Basel). 2019 Nov 28;11(12):1896. doi: 10.3390/cancers11121896. Cancers (Basel). 2019. PMID: 31795208 Free PMC article. Review.
-
Tumor-Associated Fatigue in Cancer Patients Develops Independently of IL1 Signaling.Cancer Res. 2018 Feb 1;78(3):695-705. doi: 10.1158/0008-5472.CAN-17-2168. Epub 2017 Dec 7. Cancer Res. 2018. PMID: 29217760 Free PMC article.
-
Impact of Inflammation on Myeloproliferative Neoplasm Symptom Development.Mediators Inflamm. 2015;2015:284706. doi: 10.1155/2015/284706. Epub 2015 Oct 11. Mediators Inflamm. 2015. PMID: 26538823 Free PMC article. Review.
-
A Randomized, Controlled, Parallel-Group, Trial on the Effects of Melatonin on Fatigue Associated with Breast Cancer and Its Adjuvant Treatments.Integr Cancer Ther. 2021 Jan-Dec;20:1534735420988343. doi: 10.1177/1534735420988343. Integr Cancer Ther. 2021. PMID: 33543655 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical